Acute myocardial infarction: an episodic event of several coronary spasms followed by dilatation?
Related Experiment Videos
Insights
Acute myocardial infarction (AMI) involves repeated coronary artery spasms, not a single event. This cycle, driven by platelets and ischemic tissue, can be interrupted by thrombolytic drugs like streptokinase.
Area of Science:
- Cardiology
- Vascular Biology
- Thrombosis
Background:
- Acute myocardial infarction (AMI) is increasingly understood as a series of recurrent episodes rather than a singular event.
- The initial phase of AMI may involve coronary artery spasm induced by substances released from aggregated platelets.
- Subsequent tissue ischemia leads to substance release, causing vasodilation and mediator washout.
Purpose of the Study:
- To elucidate the cyclical nature of acute myocardial infarction.
- To describe the thrombo-ischemic re-entry mechanism in AMI.
- To identify potential interruption points for the AMI cycle.
Main Methods:
- Observational analysis of the temporal sequence of events in AMI.
- Characterization of vasoactive mediator release and platelet aggregation during AMI episodes.
- Evaluation of the effect of thrombolytic agents on the AMI cycle.
Main Results:
- AMI is characterized by a vicious circle of coronary artery spasm, vasodilation, and re-contraction.
- Platelet aggregation and release of vasoconstrictive substances initiate spasms.
- Washout of mediators and platelets during dilation is reflected in blood myoglobin peaks.
- Thrombo-ischemic re-entry mechanisms are repeatedly observed.
- Systemic administration of streptokinase can interrupt this cycle.
Conclusions:
- Acute myocardial infarction is a dynamic, episodic process involving a thrombo-ischemic re-entry mechanism.
- Understanding this cycle provides targets for therapeutic intervention.
- Thrombolytic therapy, such as with streptokinase, offers a means to break the cycle of recurrent myocardial infarction episodes.
Abstract:
Acute myocardial infarction (AMI) can no longer be considered as a single event, but as a series of episodes. In most of the cases, the initial event may be the induction of a severe spasm of the coronary artery by vasoconstrictive substance released from aggregated platelets. These spasms are followed by dilatation, which is caused by substances set free from the ischemic tissue. Dilatation then results in a washing-out of vasoactive mediators (as well as myoglobin) and platelets, which is reflected as a peak in the blood myoglobin concentration-time curve. The local depletion of vasodilative metabolites allows a further contraction of the coronary vessel. A new accumulation of platelets then stimulates another spasm. This vicious circle (thrombo-ischemic re-entry-mechanism) is repeated several times and can be interrupted by the systemic administration of thrombolytic drugs (streptokinase).